US equities |
SPCX $171.09 ▲+0.00% NVDA $238.90 ▲+0.00% MU $1,063.96 ▲+0.00% SNDK $1,704.16 ▲+0.00% AMD $631.75 ▲+0.00% SDEV $3.94 ▲+0.00% SKHY $195.02 ▲+0.00% TSLA $378.73 ▲+0.00%
FinancialContent

Articles published by Hummingbird Bioscience

News headline image
Hummingbird Bioscience Announces First Patient Dosed in Phase II Trial of HMBD-001 and Cetuximab in Advanced Squamous Cell Cancers
From Hummingbird Bioscience
Via GlobeNewswire
News headline image
Hummingbird Bioscience Appoints Dr. James Garner as President
From Hummingbird Bioscience
Via GlobeNewswire
News headline image
Hummingbird Bioscience Wins APAC Trailblazer Award at 2026 Nebius AI Discovery Awards
From Hummingbird Bioscience
Via GlobeNewswire
News headline image
Hummingbird Bioscience Announces First Patient Dosed in Phase I Clinical Trial of HMBD-501 in Advanced HER3-Expressing Solid Malignancies
From Hummingbird Bioscience
Via GlobeNewswire
News headline image
Hummingbird Bioscience Licenses HMBD-002, Phase II-Ready Anti-VISTA Monoclonal Antibody to Percheron Therapeutics
From Hummingbird Bioscience
Via GlobeNewswire
Tickers ASX:PER PERCF
News headline image
Hummingbird Bioscience Licenses Novel Antibodies to Immunome
From Hummingbird Bioscience
Via GlobeNewswire
Tickers IMNM
News headline image
Hummingbird Bioscience Announces Poster Presentation on HMBD-802, Novel Dual-Payload Antibody-Drug Conjugate, at EORTC-NCI-AACR 2024
From Hummingbird Bioscience
Via GlobeNewswire
News headline image
Hummingbird Bioscience Announces Key Leadership Appointments
From Hummingbird Bioscience
Via GlobeNewswire
News headline image
Hummingbird Bioscience Presents New Preclinical Data Highlighting Next-Generation Antibody-Drug Conjugate Capabilities at PEGS Boston 2024
From Hummingbird Bioscience
Via GlobeNewswire